| 11 545 patients | P | 218 patients | P | ||
---|---|---|---|---|---|---|
N (%) | Mean incubation period (95% CI) | N (%) | Mean incubation period (95% CI) | |||
Total | 11 545 (100%) | 7.1 (7.0–7.2) |  | 218 (100%) | 6.8 (6.2–7.4) |  |
Gender | 0.603 | Â | Â | 0.145 | ||
 Male | 5814 (52.7%) | 7.2 (7.0–7.4) |  | 121 (56.3%) | 6.3 (5.4–7.2) |  |
 Female | 5215 (47.3%) | 7.1 (6.9–7.3) |  | 94 (43.7%) | 7.5 (6.7–8.4) |  |
Age, years | < 0.001 |  |  | 0.009 | ||
 < 18 | 460 (4.4%) | 8.6 (8.0–9.3) |  | 6 (2.8%) | 9.3 (5.3–16.3) |  |
 18–40 | 3789 (36.3%) | 7.2 (7.0–7.4) |  | 73 (34.1%) | 7.7 (6.6–9.0) |  |
 41–60 | 4425 (42.3%) | 7.1 (6.9–7.2) |  | 98 (45.8%) | 5.7 (4.9–6.6) |  |
 > 60 | 1777 (17.0%) | 7.0 (6.6–7.3) |  | 37 (17.3%) | 8.0 (6.5–9.8) |  |
The date of onset | Â | Â | 0.319 | Â | Â | Â |
 Reported date of onseta | 7303 (63.2%) | 7.1 (7.0–7.3) |  |  |  |  |
 Date of first treatment minus 2.5 daysb | 2168 (18.8%) | 7.0 (6.7–7.3) |  |  |  |  |
 Date of diagnosis minus 5.4 daysc | 2074 (18.0%) | 7.3 (7.0–7.6) |  |  |  |  |